Business
Health
A Rare Kidney Disease Approval Turns Travere Therapeutics Profitable While Hedge Funds Split on the Stock
By Raj Gupta
Travere Therapeutics shares closed at $57.36 on July 24, more than triple the $15.03 low…
Home
Sydney is Australia’s busiest commercial hub, home to major financial institutions, global headquarters, tech giants,…
Every workplace relies on air conditioning to maintain a comfortable environment. Yet, many delay office…
For those who value peace but still crave connection, coliving offers a middle ground. It’s…
Pressing clothes may look straightforward, but a few wrong moves can turn your neat shirt…